Clinical trials: Fertility Risk
Fertility Risk
Anti-Mullerian Hormone - At My Home
The AMH^2 (Anti-Mullerian Hormone - At My Home) study is a head-to-head-to-head validation study aiming to evaluate the concordance of AMH levels found in blood collected via three different routes: collected at-home using the…
- Trial name
- AMH^2 (NCT04784325)
- Testing
- Blood draw through TAP II, Blood draw through ADx cardT, Blood draw through standard venipuncture
- Where
- United States
- Volunteers
- 41 people, healthy volunteers welcome
- Sponsor
- Turtle Health, Inc.
Fertility Risk
Care Expansion Across Remote Environments - Sub-Study of the SELF-GYN1 Trial
This real-world, interventional sub-study will evaluate the impact of potential payer subsidies for Turtle Health at-home consults on subsequent interactions with the healthcare system within select sub-populations of interest.
- Trial name
- CARE (NCT05509322)
- Testing
- Subsidy for fertility consult, Invitation to purchase fertility consult
- Where
- United States
- Sponsor
- Turtle Health, Inc.
Fertility Risk
SELF-GYN1 (Sonograms Enable Looking Forward- Get Your iNformation 1 Trial)
This clinical trial will evaluate the efficacy and safety of the use of the Turtle Health Ultrasound Scanner for the acquisition of transvaginal ultrasound images by a study participant, with no previous training, in her home…
- Trial name
- SELF-GYN1 (NCT05443698)
- Testing
- Transvaginal ultrasound
- Where
- 2 sites in United States
- Volunteers
- 365 people, healthy volunteers welcome
- Sponsor
- Turtle Health, Inc.
Fertility Risk
Sonograms Enable Looking Forward - Home Examinations Led by Providers Validation Study
To demonstrate that clear, interpretable quality images of the ovaries and uterus can be generated using a portable transvaginal ultrasound scanner in the home environment, and that those images are interpretable by physicians…
- Trial name
- SELF-HELP (NCT04687189)
- Testing
- Transvaginal ultrasound performed by a woman herself (with HCP supervision via telemedicine)
- Where
- United States
- Volunteers
- 56 people, healthy volunteers welcome
- Sponsor
- Turtle Health, Inc.
Contraception, Female Contraception
Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.
This study uses the PharMetrics and MarketScan US health care insurance claims database to estimate relative risks for non-fatal venous thromboembolism (including cerebral venous sinus thrombosis), ischemic stroke, and acute…
- Conditions
- Contraception, Female Contraception, Fertility Control
- Trial name
- NCT00511784
- Volunteers
- 440 people, healthy volunteers welcome
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.